pyrazines has been researched along with Alcoholic Fatty Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, A; Lu, C; Shao, J; Xu, W; Zhang, F; Zheng, S | 1 |
Li, LH; Liao, Y; Wu, HF; Zhu, ZJ; Zuo, GQ | 1 |
Bardag-Gorce, F; French, SW; Li, J; Oliva, J | 1 |
3 other study(ies) available for pyrazines and Alcoholic Fatty Liver
Article | Year |
---|---|
Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
Topics: Animals; Cells, Cultured; Ethanol; Fatty Liver, Alcoholic; Gene Knockdown Techniques; Hepatocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Metabolism; Male; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Pyrazines; Signal Transduction | 2017 |
[Effect of ligustrazine hydrocklorde on induced alcoholic fatty liver in vitro].
Topics: Cell Line; Fatty Liver, Alcoholic; Hepatocytes; Humans; Pyrazines | 2010 |
Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.
Topics: Alcohol Drinking; Animals; Antineoplastic Agents; Apolipoproteins; Boronic Acids; Bortezomib; Cholesterol; Down-Regulation; Fatty Acids; Fatty Liver, Alcoholic; Intestinal Absorption; Lipid Metabolism; Male; Proteasome Inhibitors; Pyrazines; Rats; Rats, Wistar; Triglycerides | 2012 |